Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.

  title={Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.},
  author={V{\'i}ctor J Su{\'a}rez and Fabiana Michel and Cristiana M Toscano and Ana Luiza Bierrenbach and Marco L Gonzales and Airlane Pereira Alencar and Cuauht{\'e}moc Ruiz Matus and Jon Kim Andrus and L{\'u}cia Helena de Oliveira},
  volume={34 39},
Streptococcus pneumoniae is the leading cause of bacterial pneumonia, meningitis and sepsis in children worldwide. Despite available evidence on pneumococcal conjugate vaccine (PCV) impact on pneumonia hospitalizations in children, studies demonstrating PCV impact in morbidity and mortality in middle-income countries are still scarce. Given the disease burden, PCV7 was introduced in Peru in 2009, and then switched to PCV10 in late 2011. National public healthcare system provides care for 60% of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 24 references

The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean

  • D Constenla, E Gomez, F Pio de la Hoz, R O’Loughlin, A Sinha, JE Valencia
  • 2007
Highly Influential
5 Excerpts

Inmunización conceptos generales esquemas y el futuro. Rev peru pediatr 2008;61:36–43

  • C Verne Martin, C. Ugarte Taboada
  • 2008
Highly Influential
1 Excerpt

introduction in selected countries of the Latin American Region

  • S Sgambatti, R Minamisava, ET Afonso, CM Toscano, AL Bierrenbach, AL Andrade
  • 2013

Estudio de costo efectividad de las vacunas deca- y trece-valente para la prevención de enfermedad asociada a Streptococcus pneumoniae en niños menores de 5 años en Perú

  • Peru. Ministerio de Salud
  • Nota Técnica
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…